In terms of pharmacotherapy, there is reasonable consensus that SSRIs and other antidepressant drugs are associated with increases in BDNF levels in the periphery and brain [39, 40], providing a possible explanation for the beneficial role of the neurotrophin in anxiety disorders, such as PTSD. Here, BDNF is linked to post-traumatic stress disorder.